Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis C, Chronic

Clinical trial condition

Hepatitis C, Chronic

Explore clinical trials studying Hepatitis C, Chronic. Study availability and eligibility vary by location and protocol.

699 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis C, Chronic trial results

Completed

A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis

NCT01516918

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus, +15 more
Locations: Birmingham, Alabama, United States

San Diego, California, United States

Englewood, Colorado, United States

Bradenton, Florida, United States

View all 43 locations

View Trial Details

Completed

High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1

NCT00735969

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

A Phase Ⅱ Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis C

NCT01908335

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China

First Affiliated Hospital of Lanzhou University Lanzhou, Gansu, China

Guangdong General Hospital Guangzhou, Guangdong, China

Guangzhou Eighth People's Hospital Guangzhou, Guangdong, China

View all 52 locations

View Trial Details

Completed

Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C Patients

NCT01581398

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: 302 Military Hospital Beijing, China

Beijing Youan Hospital, Capital Medical University Beijing, China

Beijing Youyi Hospital, capital Medical University Beijing, China

Peking University First Hospital Beijing, China

View all 42 locations

View Trial Details

Completed

Evaluation of the Antiviral Pharmacodynamic Effect, Safety, and Pharmacokinetics of Escalating Doses of BILB 1941 ZW to Patients With Chronic Hepatitis C Genotype 1 Virus Infection

NCT02254707

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Study of the Impact of Nitazoxanide on Chronic Hepatitis Patients

NCT01197157

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: National Liver Institute Shebin El-Kom, Monufia Governorate, Egypt

View Trial Details

Completed

Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen

NCT00286871

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3

NCT01808248

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +17 more
Locations: Alamo Medical Research San Antonio, Texas, United States

View Trial Details

Completed

Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in Patients With HCV G1/4

NCT01884402

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Fundación Pública Andaluza para la Gestión de la investigación en salud de Sevilla (FISEVI) Seville, Sevilla, Spain

Fundación Pública Andaluza para la Gestión de la investigación en salud de Sevilla (FISEVI) Seville, Spain

View Trial Details

Completed

Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.

NCT00323804

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +17 more
Locations: CHU Brugmann Brussels, Belgium

Hôpital Bracops Brussels, Belgium

Hôpital Erasme Brussels, Belgium

Hôpital de Jolimont La Louvière, Belgium

View all 45 locations

View Trial Details